Search Within

Maria Eugenia Arcila

Formats
  1. Meeting Abstract (391)
  2. Journal Article (247)
  3. Research Letter (12)
  4. Book Section (8)
  5. Review (7)
  6. Editorial (2)
  7. Guidelines (2)
  8. Book Whole (1)
Groups
  1. Department of Pathology and Laboratory Medicine (670)
  2. Department of Medicine (458)
  3. GSK Faculty (456)
  4. Human Oncology and Pathogenesis Program (427)
  5. Tow Center for Developmental Oncology (TCDO) (346)
  6. Solid Tumor Oncology Division (317)

More Groups

People
  1. Marc Ladanyi (301)
  2. Michael Berger (163)
  3. Ahmet Zehir (126)
  4. Mark Kris (123)
  5. Khedoudja Nafa (108)
  6. Ryma Benayed (99)

More People

Years
  1. 2025 (11)
  2. 2024 (29)
  3. 2023 (43)
  4. 2022 (32)
  5. 2021 (37)
  6. 2020 (68)

More Years

Publications
  1. Journal of Molecular Diagnostics (93)
  2. Journal of Clinical Oncology (80)
  3. Laboratory Investigation (74)
  4. Modern Pathology (69)
  5. Blood (55)
  6. Clinical Cancer Research (36)

More Publications

Publishers
  1. Elsevier Science, Inc. (98)
  2. Nature Publishing Group (97)
  3. American Society of Clinical Oncology (96)
  4. Nature Research (69)
  5. American Association for Cancer Research (61)
  6. American Society of Hematology (61)

More Publishers

Results (670)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive assessment of targetable somatic alterations in cytologic cell block material using a clinical, hybrid capture-based, next-generation sequencing assay
    Meeting Abstract

    Sadowska, J.; Zehir, A.; Benayed, R.; Ladanyi, M.; Lin, O.; Arcila, M.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Comprehensive assessment of targetable somatic alterations in cytologic cell block material using a clinical, hybrid capture-based, next-generation sequencing assay
    Meeting Abstract

    Sadowska, J.; Zehir, A.; Benayed, R.; Ladanyi, M.; Lin, O.; Arcila, M.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling of chronic myelomonocytic leukemia in routine clinical practice - MSKCC experience
    Meeting Abstract

    Pal, P.; Dogan, A.; Arcila, M.; Rampal, R.; Wang, L.; Chiu, A.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling of chronic myelomonocytic leukemia in routine clinical practice - MSKCC experience
    Meeting Abstract

    Pal, P.; Dogan, A.; Arcila, M.; Rampal, R.; Wang, L.; Chiu, A.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • RNA based next generation sequencing (NGS) assay to detect gene fusions in translocation associated sarcomas
    Meeting Abstract

    Jour, G.; Benayed, R.; O Reilly, C.; Ladanyi, M.; Arcila, M.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • RNA based next generation sequencing (NGS) assay to detect gene fusions in translocation associated sarcomas
    Meeting Abstract

    Jour, G.; Benayed, R.; O Reilly, C.; Ladanyi, M.; Arcila, M.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Comprehensive assessment of RAS/RAF mutation status and identification of alternative targetable driver alterations in RAS/RAF wild type colorectal carcinoma using a hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J.; Zehir, A.; Cheng, D.; Shia, J. R.; Solit, D.; Yaeger, R.; Hyman, D.; Arcila, M.; Berger, M.; Ladanyi, M.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Comprehensive assessment of RAS/RAF mutation status and identification of alternative targetable driver alterations in RAS/RAF wild type colorectal carcinoma using a hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J.; Zehir, A.; Cheng, D.; Shia, J.; Solit, D.; Yaeger, R.; Hyman, D.; Arcila, M.; Berger, M.; Ladanyi, M.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • AKT1 E17K in colorectal carcinoma is associated with BRAF V600E but not MSI-H status: A clinicopathologic comparison to PIK3CA helical and kinase domain mutants
    Meeting Abstract

    Hechtman, J.; Sadowska, J.; Huse, J.; Borsu, L.; Yaeger, R.; Shia, J. R.; Vakiani, E.; Ladanyi, M.; Arcila, M.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • AKT1 E17K in colorectal carcinoma is associated with BRAF V600E but not MSI-H status: A clinicopathologic comparison to PIK3CA helical and kinase domain mutants
    Meeting Abstract

    Hechtman, J.; Sadowska, J.; Huse, J.; Borsu, L.; Yaeger, R.; Shia, J.; Vakiani, E.; Ladanyi, M.; Arcila, M.
    Modern Pathology (2015)

    Fulltext@MSK | Save